These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31289536)

  • 1. Iodine promotes thyroid cancer development via SPANXA1 through the PI3K/AKT signalling pathway.
    Yang X; Sun J; Han J; Sun L; Wang H; Zhang D; Fang Q; Liu J; Qiao H
    Oncol Lett; 2019 Jul; 18(1):637-644. PubMed ID: 31289536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway.
    Liang W; Lai Y; Zhu M; Huang S; Feng W; Gu X
    Med Sci Monit; 2016 Dec; 22():4911-4917. PubMed ID: 27966519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
    Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
    Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptotanshinone Inhibites Bladder Cancer Cell Proliferation and Promotes Apoptosis via the PTEN/PI3K/AKT Pathway.
    Liu Y; Lin F; Chen Y; Wang R; Liu J; Jin Y; An R
    J Cancer; 2020; 11(2):488-499. PubMed ID: 31897244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringin inhibits thyroid cancer cell proliferation and induces cell apoptosis through repressing PI3K/AKT pathway.
    Zhou J; Xia L; Zhang Y
    Pathol Res Pract; 2019 Dec; 215(12):152707. PubMed ID: 31727500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin regulates cell autophagy in endometrial cancer cells via the PI3K/AKT/mTOR signalling pathway.
    Lin Q; Wang Y; Chen D; Sheng X; Liu J; Xiong H
    Oncol Lett; 2017 May; 13(5):3567-3571. PubMed ID: 28521459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
    Ma Y; Qin H; Cui Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.
    Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M
    Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the AKT/mTOR Pathway Augments the Anticancer Effects of Sorafenib in Thyroid Cancer.
    Yi H; Ye X; Long B; Ye T; Zhang L; Yan F; Yang Y; Li L
    Cancer Biother Radiopharm; 2017 Jun; 32(5):176-183. PubMed ID: 28622037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.
    Li Q; Lai Z; Yan Z; Peng J; Jin Y; Wei L; Lin J
    Mol Med Rep; 2018 Jan; 17(1):358-365. PubMed ID: 29115462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells
    Pan HM; Lang WY; Yao LJ; Wang Y; Li XL
    World J Gastrointest Oncol; 2019 Aug; 11(8):622-633. PubMed ID: 31435463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.
    Wu YR; Qi HJ; Deng DF; Luo YY; Yang SL
    Tumour Biol; 2016 Sep; 37(9):12061-12070. PubMed ID: 27188433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA H19 knockdown inhibits the cell viability and promotes apoptosis of thyroid cancer cells through regulating the PI3K/AKT pathway.
    Li X; Li Q; Jin X; Guo H; Li Y
    Exp Ther Med; 2019 Sep; 18(3):1863-1869. PubMed ID: 31410148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway.
    Zhang P; Wang C; Ma T; You S
    Onco Targets Ther; 2015; 8():3305-13. PubMed ID: 26635480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway.
    Li A; Gu Y; Li X; Sun H; Zha H; Xie J; Zhao J; Huang M; Chen L; Peng Q; Zhang Y; Weng Y; Zhou L
    Oncol Lett; 2018 Apr; 15(4):5685-5693. PubMed ID: 29552203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.